EXHIBIT 2.3Escrow Agreement • June 21st, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
1 EXHIBIT 4.5 NEITHER THIS WARRANT, NOR THE SHARES OF COMMON STOCK FOR WHICH IT IS EXERCISABLE, HAVE BEEN REGISTERED FOR SALE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, ANY APPLICABLE SECURITIES LAWS OF THE STATE OF DELAWARE, OR OTHER APPLICABLE...Cytrx Corp • November 6th, 1997 • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of January 20, 2005, among CytRx Corporation, a Delaware corporation (the "Company"), and the purchasers signatory hereto...Registration Rights Agreement • January 21st, 2005 • Cytrx Corp • Biological products, (no disgnostic substances)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 15th, 2021 • Cytrx Corp • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 13, 2021, between CytRx Corporation, a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (the “Purchaser”).
LICENSE AGREEMENT between VICAL INCORPORATED and CYTRX CORPORATIONLicense Agreement • December 21st, 2001 • Cytrx Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 2.4Cytrx Corp • June 21st, 2000 • Biological products, (no disgnostic substances)
EXHIBIT 10.4 AMENDED AND RESTATED CHANGE IN CONTROL EMPLOYMENT AGREEMENT BETWEEN CYTRX CORPORATION AND JACK J. LUCHESE AMENDED AND RESTATED CHANGE IN CONTROL EMPLOYMENT AGREEMENT AGREEMENT by and between CytRx Corporation, a Delaware corporation (the...Employment Agreement • March 30th, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.11 Lease Agreement dated February 16, 1998 by and between Proceutics, Inc. and Oread, Inc. LEASE BY AND BETWEENLease Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
RECITALConsulting Agreement • May 17th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
BY AND BETWEENPurchase and Sale Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
BACKGROUNDRegistration Rights Agreement • November 6th, 1997 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of October 4, 2004, among CytRx Corporation, a Delaware corporation (the "Company"), and the purchasers signatory hereto (each...Registration Rights Agreement • October 5th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances)
1 EXHIBIT 10.12 COMMON STOCK PURCHASE AGREEMENT DATED MARCH 24, 2000 BY AND BETWEEN CYTRX CORPORATION AND THE INVESTORS SIGNATORY THERETO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 30th, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • January 21st, 2005 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
9,100,000 Shares CytRx Corporation UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2015 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 20th, 2015 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20 between CYTRX CORPORATION, a Delaware corporation (the “Company”), and (“Indemnitee”).
OFFICE LEASE BETWEENOffice Lease • May 14th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
SUBLEASESublease Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
LICENSE AGREEMENT between VICAL INCORPORATED and CYTRX CORPORATIONLicense Agreement • May 13th, 2002 • Cytrx Corp • Biological products, (no disgnostic substances) • California
COMMON STOCK PURCHASE WARRANT CYTRX CORPORATIONCommon Stock Purchase Warrant • March 15th, 2017 • Cytrx Corp • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the one year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from CytRx Corporation, a Delaware corporation (the "Company"), up to _______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 14th, 2016 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 13, 2016, between CytRx Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.7 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made and entered into as of September 17, 2003 (the "Effective Date") by and between Araios, Inc., a Delaware corporation ("Employer"), and Mark A. Tepper, an individual...Employment Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Cytrx Corp • October 5th, 2004 • Biological products, (no disgnostic substances)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 16th, 2018 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this "Agreement") is dated as of May 11, 2018, between CytRx Corporation, a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively the "Purchasers").
EXHIBIT 2.1 ACQUISITION AGREEMENTNon-Competition Agreement • May 1st, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
RECITALSConsulting Agreement • May 14th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (this "Agreement") is made and entered into as of September 15, 2003, by and among CytRx Corporation, a Delaware corporation (the "Company"),...Registration Rights Agreement • September 17th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 15th, 2021 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 13, 2021, between CytRx Corporation, a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).
EXHIBIT 10.11 STOCKHOLDERS AGREEMENT (this "Agreement") made and entered into effective as of September 17, 2003 by and among Araios, Inc., a Delaware corporation (the "Corporation"), and the Stockholders (as hereinafter defined), with reference to...Stockholders Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Exhibit 2.1 ----------- PURCHASE AGREEMENT ------------------ THIS AGREEMENT is made and entered into this 15th day of June 2000, between CYTRX CORPORATION, a Delaware corporation ("Seller"), and TITERMAX USA, INC., a Georgia corporation ("Buyer"). In...Purchase Agreement • June 23rd, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
10,000,000 Shares of Common Stock CYTRX CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2013 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Ex 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made and entered into as of July 6, 2004 (the "Effective Date") by and between CytRx Corporation, a Delaware corporation ("Employer"), and Jack Barber, an individual and...Employment Agreement • August 16th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
andSale and Purchase Agreement • October 5th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 99 CYTRX CORPORATION PRO FORMA FINANCIAL INFORMATION On December 7, 2001, CytRx Corporation entered into a license agreement (the "License Agreement") with Vical, Incorporated ("Vical") granting Vical exclusive, worldwide rights to use or...Cytrx Corp • January 11th, 2002 • Biological products, (no disgnostic substances)
AGREEMENTAgreement • May 14th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • Texas
